The University of Toledo

Center for Clinical Research : Active Malanoma protocols       Study number links to NCI protocol site

Skip to menu | Skip to content | Skip to search | Skip to global navigation
  • Home
  • About UT
  • Directions/Maps
  • Campus Directory
  • Contact
  • myUT
  • Advanced Search
  • Text Only
  • Feedback
  • Prospective Students
  • Admission
  • Academics
  • Campus Life
  • Current Students
  • Faculty & Staff
  • Research
  • Athletics
  • Alumni & Community
  • Print
Center for Clinical Research
  • No top menu
    • <!-- no script -->
    Select an Organ Site
    • Brain
    • Breast
    • Genitourinary
    • GI
    • GYN
    • Hematology
    • Melanoma
    • Cooperative Groups
    Generic
    no links

    Active Malanoma protocols       Study number links to NCI protocol site

    Adjuvant

    • E1697 - Phase III Randomized Adjuvant Study of High-Dose Interferon alfa-2b Therapy in Patients With Stage II or III Melanoma

    Melanoma

    • N057E - Phase II Study of Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation (ABI-007) in Patients With Unresectable Stage IV Melanoma

    Page updated: February 01, 2008
    Page top
    • Prospective Students
    • Admission
    • Academics
    • Campus Life
    • Current Students
    • Faculty & Staff
    • Research
    • Athletics
    • Alumni & Community
    The University of Toledo • 2801 W. Bancroft • Toledo, OH 43606-3390 • 1.800.586.5336
    © 2006-2008 The University of Toledo. All rights reserved. • Send all feedback / comments to webmaster.
    • Terms of Use